CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,585 | -19.2% | 674 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $37,830 | +24.1% | 674 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $30,477 | +11.2% | 674 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $27,397 | +95.7% | 674 | +224.0% | 0.00% | – |
| Q3 2022 | $14,000 | +7.7% | 208 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | 0.0% | 208 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -13.3% | 208 | +4.5% | 0.00% | – |
| Q4 2021 | $15,000 | -88.1% | 199 | -82.3% | 0.00% | -100.0% |
| Q3 2021 | $126,000 | -30.8% | 1,123 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $182,000 | +32.8% | 1,123 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $137,000 | +356.7% | 1,123 | +464.3% | 0.00% | +200.0% |
| Q4 2020 | $30,000 | +76.5% | 199 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | +13.3% | 199 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +87.5% | 199 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -33.3% | 199 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +50.0% | 199 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 199 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | +28.6% | 199 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +16.7% | 199 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 199 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -25.0% | 199 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |